Analyst Vincent Andrews from Morgan Stanley maintained a Buy rating on Corteva and keeping the price target at $84.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Vincent Andrews has given his Buy rating due to a combination of factors that reflect Corteva’s financial outlook and strategic decisions. The company’s earnings per share (EPS) estimates have been adjusted upward for the full year 2025, indicating a positive growth trajectory despite a slight revision downward for the fourth quarter of 2025. This adjustment is largely attributed to the strategic pull forward of seed sales into the third quarter, which suggests a proactive management approach to optimize financial performance.
Additionally, Corteva’s EBITDA forecasts have been revised to reflect a stronger performance in the Crop Protection segment, even as the Seed segment shows a temporary decline due to the aforementioned sales shift. The anticipated separation of the Seed and Crop Protection businesses is expected to create some dis-synergies, but the overall outlook remains robust. The company’s recent quarterly results surpassed expectations, reinforcing confidence in its operational execution and future potential.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $70.00 price target.
Based on the recent corporate insider activity of 70 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CTVA in relation to earlier this year.